- Author:
Qi ZENG
1
;
Yuehua ZHANG
;
Xiaoling YANG
;
Xiaojing XU
;
Jing ZHANG
;
Xiaojuan TIAN
;
Aijie LIU
;
Xiaoyan LIU
;
Yuwu JIANG
;
Xiru WU
Author Information
- Publication Type:Journal Article
- MeSH: Epilepsies, Myoclonic; genetics; Female; Gene Deletion; Gene Duplication; Humans; Infant; Male; Multiplex Polymerase Chain Reaction; NAV1.1 Voltage-Gated Sodium Channel; genetics
- From: Chinese Journal of Medical Genetics 2017;34(6):787-791
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo determine the type and frequency of SCN1A deletions and duplications among patients with Dravet syndrome (DS).
METHODSFor DS patients in which no mutations of the SCN1A gene were detected by PCR-DNA sequencing, SCN1A deletions and duplications were detected by multiplex ligation-dependent probe amplification (MLPA).
RESULTSIn 680 DS patients, 489 had SCN1A mutations identified by PCR-DNA sequencing. In 191 patients who were negative for the SCN1A PCR-DNA sequencing, 15 (15/191, 7.9%) were detected with heterozygous SCN1A deletions or duplications, which included 14 (14/15, 93.3%) SCN1A deletions and 1 SCN1A duplication. There were 13 types of mutations, including whole SCN1A deletions in 3 patients, partial SCN1A deletions in 11 patients and partial SCN1A duplications in one patient. By testing the parents, 14 mutations were found to be de novo. For the remaining case, no SCN1A deletion or duplication was found in the mother, while the father was not available.
CONCLUSIONApproximately 8% of Chinese patients who were negative for SCN1A mutation by PCR-sequencing have SCN1A deletions or duplications. The MLPA analysis should be considered as an important strategy for such patients. SCN1A deletions are more common than SCN1A duplications among DS patients, and the most common types are whole SCN1A deletions. The majority of SCN1A deletions or duplications are de novo.